A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its ...
A European consortium of researchers has developed a new decision making framework for health professionals which they hope ...
Patients with chronic obstructive pulmonary disease (COPD) that is in a state of disease stability (DS) have fewer exacerbations and lower mortality, according to study findings published in Chest.
In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The likelihood for in-hospital mortality was decreased ...
In conjunction with World Chronic Obstructive Pulmonary Disease (COPD) Day, organised by the World Health Organisation and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), a research ...
Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.
University of Houston researchers have developed a single-shot X-ray imaging method that captures three types of contrast at ...
COPD experimental therapy 9MW1911 reduced moderate to severe exacerbations in a Phase 2a trial, showing a favorable safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback